Could a cancer vaccine developed long ago hold the key to long-term survival in breast cancer?​Could a cancer vaccine developed long ago hold the key to long-term survival in breast cancer? 

A small group of women with advanced breast cancer received a vaccine via a clinical trial more than 20 years ago. Today, they’re all still alive. Scientists say that kind of long-term survival is almost unheard of for patients with metastatic breast cancer, and it’s what caught the attention of researchers now.

Prescribing Trends of GLP-1 Receptor Agonists for Type 2 Diabetes or Obesity​Prescribing Trends of GLP-1 Receptor Agonists for Type 2 Diabetes or Obesity 

This cross-sectional study examines the US prescribing trends of glucagon-like peptide 1 (GLP-1) receptor agonists among individuals with type 2 diabetes and/or obesity. ​This cross-sectional study examines the US prescribing trends of glucagon-like peptide 1 (GLP-1) receptor agonists among individuals with type 2 diabetes and/or obesity.